■ 学術雑誌
|
原著
|
|
1.
|
朴 将源, 佐々木 香る, 坂口 恵子, 坂口 ひとみ, 藤井 良平, 石本 敦子, 北 正人, 金井 雅史, 倉田 宝保：
Tisotumab Vedotin導入におけるOnco-Ophthalmology連携体制の構築と眼有害事象の初期経験.
癌と化学療法
53
(7)
：459
-461
, 2026
|
|
2.
|
Manami Tada, Yuichiro Kikawa, Nobuhiro Shibata, Chie Hirai, Hirotsugu Yanai, Masahiro Takada, Tomoharu Sugie：
Efficacy of olanzapine for prophylaxis of delayed chemotherapy-induced nausea and vomiting in patients with breast cancer receiving dose-dense AC with a steroid-sparing regimen: a single-center pilot study.
BMC Cancer
26
(1)
, 2026
|
|
3.
|
Yukinori Ozaki, Shohei Koyama, Satoshi Morita, Minoru Miyashita, Emi Tokuda, Tatsunori Shimoi, Megumi Fukuoka, Hiroko Masuda, Yuko Takano, Nobuhiro Shibata, Tetsuhiro Yoshinami, Akari Murakami, Kentaro Tamaki, Hiroshi Ishiguro, Shigehira Saji, Asako Miwa, Junko Matsunaga, Yue Zheng, Hiroyoshi Nishikawa, Norikazu Masuda：
Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10).
BMJ open
16
(5)
：e098088
, 2026
|
|
4.
|
Masashi Kanai, Kuniko Sunami, Tatsunori Shimoi, Satoshi Nishiwaki, Ichiro Kinoshita, Tetsuhiro Yoshinami, Chigusa Morizane, Yusuke Sato, Toshio Kubo, Mamoru Ito, Hiroshi Nishihara, Toru Mukohara, Hidekazu Shirota, Ryo Ko, Taro Shibata, Manabu Muto, Noboru Yamamoto：
Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.
Cancer science
117
(10)
：2819
-2826
, 2026
|
|
5.
|
Kohei Nagata, Ichiro Yasuda, Yuko Ueda, Hiroki Kawanaka, Jun Sakamoto, Banri Ogino, Toshiki Entani, Iori Motoo, Nobuhiko Hayashi, Takayuki Ando, Shinya Kajiura, Kazuto Tajiri：
Clinical trajectories from first-line chemotherapy to best supportive care in unresectable pancreatic cancer: a 10-year real-world retrospective study.
Cancer treatment and research communications
49
：101409
, 2026
|
|
6.
|
Takeshi Nagasaka, Yoshiyasu Kono, Yosuke Kito, Takayuki Ando, Yuji Negoro, Tomoyuki Abe, Hidekazu Kuramochi, Shogen Boku, Tomohiko Mannami, Junichiro Nasu, Masafumi Inoue, Masato Nakamura, Yoshihiro Okita, Yoshiaki Shindo, Takeshi Yamada, Tetsuya Maeda, Yudai Shinohara, Hiroaki Tanioka：
Residual Platinum-Induced Neuropathy and the Feasibility of Second-Line Paclitaxel-Ramucirumab Therapy in Advanced Gastric Cancer: Prospective Multicenter Evidence from Japan.
Cancers
18
(14)
：2243
, 2026
|
|
7.
|
Kyosuke Seguchi, Takao Fujisawa, Sadakatsu Ikeda, Yu Oyama, Norio Nonomura, Chigusa Morizane, Hiroji Iwata, Susumu Okano, Hidemichi Watari, Kenjiro Namikawa, Shigenori Kadowaki, Makoto Ueno, Eiji Oki, Shogen Boku, Satoshi Yuki, Wataru Yamagami, Tomohiro Nishina, Tishihiro Kudo, Naoki Takahashi, Hideaki Bando, Takayuki Yoshino, Yoshiaki Nakamura：
Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss Across Advanced Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research
32
(15)
：3277
-3288
, 2026
|
|
8.
|
Shunji Endo, Yutaka Kimura, Naotoshi Sugimoto, Ryohei Kawabata, Atsushi Takeno, Shigeyuki Tamura, Jin Matsuyama, Masato Nakamura, Hiroki Takeshita, Motohiro Imano, Atsushi Yasuda, Hironaga Satake, Shogen Boku, Masahito Kotaka, Tomohira Takeoka, Yukinori Kurokawa, Toshimasa Tsujinaka, Toshio Shimokawa, Taroh Satoh：
Long-term survival outcomes from a phase II trial of perioperative capecitabine plus oxaliplatin for advanced gastric cancer with extensive lymph node metastases: OGSG 1701.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
29
(3)
：611
-621
, 2026
|
|
9.
|
Erika Iguchi, Motoki Watanabe, Kaito Kobayashi, Shogen Boku, Wataru Nishio, Chikage Kato, Midori Morita, Koichi Sakaguchi, Michihiro Mutoh, Tomoshi Kameda, Yasuto Naoi：
Identification of ANT2 as a Druggable Target for Endocrine-Resistant ERα-Positive Breast Cancer.
International journal of molecular sciences
27
(8)
：3704
, 2026
|
|
10.
|
Mika Okazawa-Sakai, Takao Fujisawa, Tatsuyuki Chiyoda, Hiroshi Yagi, Ichinosuke Hyodo, Shogen Boku, Yoh Hayasaki, Masanori Isobe, Daisuke Shintani, Kosei Hasegawa, Tomomi Egawa-Takata, Kimihiko Ito, Kei Ihira, Hidemichi Watari, Kazuhiro Takehara, Kiyoko Kato, Hiromichi Nakajima, Kenichi Harano, Yoshiaki Nakamura, Hideaki Bando, Takayuki Yoshino, Daisuke Aoki：
cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer.
Journal of gynecologic oncology
：Online ahead of print
, 2026
|
|
11.
|
Takashi Ito, Tsukasa Ikeura, Ayaka Orino, Koh Nakamaru, Masataka Masuda, Shinji Nakayama, Daisuke Hashimoto, Masashi Kanai, Sohei Satoi, Makoto Naganuma：
Multi-hole Versus Fully Covered Self-expandable Metal Stents for Distal Biliary Obstruction in Unresectable Pancreatic Cancer.
Pancreas
：Online ahead of print
, 2026
|
|
12.
|
Kohei Nagata, Takayuki Ando, Hiroki Kawanaka, Jun Sakamoto, Banri Ogino, Toshiki Entani, Iori Motoo, Yuko Ueda, Nobuhiko Hayashi, Shinya Kajiura, Kazuto Tajiri, Ichiro Yasuda：
Chemotherapy for Unresectable Pancreatic Cancer Complicated by Disseminated Intravascular Coagulation: A Retrospective Cohort Study.
Pancreas
：Online ahead of print
, 2026
|
|
13.
|
Tatsunori Shimoi, Nobuhiro Shibata, Masahiro Kitada, Michiko Tsuneizumi, Mitsugu Yamamoto, Yukinori Ozaki, Yumi Fujimoto, Sayuri Akiyoshi, Naoki Hashimoto, Miki Yamaguchi, Yutaka Yamamoto, Norikazu Masuda, Hiroshi Tada, Takashi Yamanaka, Yuichiro Kikawa, Tetsuhiko Taira, Shizuka Nakagawa, Taizo Takashashi, Mari S. Oba, and Naoki Niikura.：
Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE.
npj Breast Cancer
12
(1)
, 2026
|
|
総説及び解説
|
|
1.
|
Tadayoshi Hashimoto, Taro Shibuki, Takao Fujisawa, Shogen Boku, Mizuho Kikuchi, Atsuko Shimizu, Tomoe Murakami, Yasutoshi Sakamoto, Izumi Miki, Naoko Iida, Haruki Kurano, Riu Yamashita, Jun Masuda, Kensuke Matsuda, Junichiro Yuda, Shugo Yajima, Shin Kobayashi, Zedao Liu, Masataka Amisaki, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Hyoju Kim, Heon Yung Gee, Hee Seung Lee, Hyun Woo Park, Takayuki Yoshino：
AI-integrated multi-omics platform to revolutionize anti-metastatic therapy development through circulating tumor cell profiling: SCRUM-MONSTAR-CTC.
International journal of clinical oncology
31
(9)
：1756
-1763
, 2026
|
|
症例報告
|
|
1.
|
Ryohei Fujii, Nobuhiro Shibata, Yuichiro Kikawa; Shinya Fujita; Yuri Noda, Mikiko Kasahara; Chie Hirai, Manami Tada; Hirotsugu Yanai; Tomoharu Sugie; Masahiro Takada：
Early-Onset Direct Antiglobulin Test-Negative Autoimmune Hemolytic Anemia Induced by Pembrolizumab in Perioperative Triple-Negative Breast Cancer: A Case Report.
Case Reports in Oncology
19
(1)
：1100
-1107
, 2026
|
|
2.
|
Shogen Boku, Takao Fujisawa, Shigenori Kadowaki, Hironaga Satake, Hisateru Yasui, Koushiro Ohtsubo, Yasushi Shimizu, Tomoyuki Otsuka, Bunya Kuze, Riu Yamashita, Taro Shibuki, Yoshiaki Nakamura, Hideaki Bando, Takayuki Yoshino, Milan Radovich, Susumu Okano：
Identification of a Novel GOLGB1-RET Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib.
JCO precision oncology
10
(7)
：e2600237
, 2026
|
|
